These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28877833)

  • 1. Effect of Lymph Node Metastasis on Change of Positive Thyroglobulin Antibody in Differentiated Thyroid Carcinoma after Initial Treatment.
    Zhang T; Song LP; Zhao T; Gao W; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):539-543. PubMed ID: 28877833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
    Zhao Y; Mu Z; Liang D; Zhang T; Zhang X; Sun D; Sun Y; Liang J; Lin Y
    Front Endocrinol (Lausanne); 2024; 15():1354426. PubMed ID: 38721144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer.
    Jo K; Kim MH; Ha J; Lim Y; Lee S; Bae JS; Jung CK; Kang MI; Cha BY; Lim DJ
    Clin Endocrinol (Oxf); 2017 Sep; 87(3):292-299. PubMed ID: 28493284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of diagnostic whole-body scanning and serum thyroglobulin in the presence of elevated serum thyrotropin during follow-up of anti-thyroglobulin antibody-positive patients with differentiated thyroid carcinoma who appeared to be free of disease after total thyroidectomy and radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Lacerda RX; dos Santos DA; Calsolari MR
    Thyroid; 2012 Feb; 22(2):113-6. PubMed ID: 22224815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of serum thyroglobulin and antithyroglobulin antibody in differentiated thyroid cancer after thyroid ablation].
    Vincze B; Sinkovics I; Keresztes S; Gergye M; Boér A; Remenár E; Péter I; Szentirmay Z; Kremmer T; Kásler M
    Magy Onkol; 2004; 48(1):27-34. PubMed ID: 15105893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between BRAFV600E, NF-κB and TgAb expression in papillary thyroid carcinoma.
    Li W; Ming H; Sun D; Li W; Wang D; Zhang G; Tan J
    Pathol Res Pract; 2017 Mar; 213(3):183-188. PubMed ID: 28214213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact factors for the outcome of the first
    Shangguan L; Fang S; Zhang P; Han S; Shen X; Geng Y; Luo D; Zhao C
    Ann Nucl Med; 2019 Mar; 33(3):177-183. PubMed ID: 30515649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
    Han N; Lu C; Li J; Wang C; Zhao Z; Zhang Y; Liu X; Si Z; Wang G; Wang Z; Li F; Wang X
    Front Endocrinol (Lausanne); 2023; 14():1222470. PubMed ID: 37810895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without
    Matrone A; Latrofa F; Torregrossa L; Piaggi P; Gambale C; Faranda A; Ricci D; Agate L; Molinaro E; Basolo F; Vitti P; Elisei R
    Thyroid; 2018 Jul; 28(7):871-879. PubMed ID: 29860933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
    Liu YQ; Li H; Liu JR; Lin YS
    Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
    [No Abstract]   [Full Text] [Related]  

  • 11. Re-ablation I-131 activity does not predict treatment success in low- and intermediate-risk patients with differentiated thyroid carcinoma.
    Prpic M; Kruljac I; Kust D; Kirigin LS; Jukic T; Dabelic N; Bolanca A; Kusic Z
    Endocrine; 2016 Jun; 52(3):602-8. PubMed ID: 26732041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Antithyroglobulin Antibody Concentrations Before and After Ablation with 131I as a Predictor of Structural Disease in Differentiated Thyroid Carcinoma Patients with Undetectable Basal Thyroglobulin and Negative Neck Ultrasonography.
    Rosario PW; Carvalho M; Mourão GF; Calsolari MR
    Thyroid; 2016 Apr; 26(4):525-31. PubMed ID: 26831821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Association of Preablation Thyroglobulin Antibody Positivity and Outcome in Pediatric Patients With Papillary Thyroid Carcinoma.
    Xu Y; Shi L; Wu J; Li H; Wang Y; Liu B
    Clin Nucl Med; 2023 Sep; 48(9):763-767. PubMed ID: 37385237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LYMPHOCYTIC THYROIDITIS IS ASSOCIATED WITH INCREASED NUMBER OF BENIGN CERVICAL NODES AND FEWER CENTRAL NECK COMPARTMENT METASTATIC LYMPH NODES IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
    Donangelo I; Walts AE; Bresee C; Braunstein GD
    Endocr Pract; 2016 Oct; 22(10):1192-1198. PubMed ID: 27732096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome.
    Trimboli P; Zilioli V; Imperiali M; Giovanella L
    Clin Chem Lab Med; 2017 Oct; 55(12):1995-2001. PubMed ID: 28467308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Low Levels of Thyroglobulin Autoantibodies Associated with Undetectable Thyroglobulin After Thyroidectomy for Differentiated Thyroid Carcinoma.
    Latrofa F; Ricci D; Sisti E; Piaggi P; Nencetti C; Marinò M; Vitti P
    Thyroid; 2016 Jun; 26(6):798-806. PubMed ID: 27020734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and implications of negative serum thyroglobulin but positive I-131 whole-body scans in patients with well-differentiated thyroid cancer prepared with rhTSH or thyroid hormone withdrawal.
    Cherk MH; Francis P; Topliss DJ; Bailey M; Kalff V
    Clin Endocrinol (Oxf); 2012 May; 76(5):734-40. PubMed ID: 22050475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to disappearance of thyroglobulin antibodies and influencing factors in patients with papillary thyroid carcinoma.
    Li TJ; Lin YS; Liang J; Li F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):258-61. PubMed ID: 22776660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithyroglobulin Antibody Variation During Follow-Up Has a Good Prognostic Value for Preoperative Antithyroglobulin Antibody-Positive Differentiated Thyroid Cancer Patients: A Retrospective Study in Southwest China.
    Liu Q; Yin M; Li G
    Front Endocrinol (Lausanne); 2021; 12():774275. PubMed ID: 34975751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.
    Chang YW; Kim HS; Jung SP; Kim HY; Lee JB; Bae JW; Son GS
    Int J Clin Oncol; 2016 Oct; 21(5):862-868. PubMed ID: 26837274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.